Total Holdings
85
Portfolio diversification across 85 positions
WDNA
(BATS)WisdomTree BioRevolution Fund
$17.98-- (--)
Loading... - Market loading
WDNA ETF Holdings: WisdomTree BioRevolution Fund
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$2.72M
Total fund assets
Expense Ratio
0.45%
Annual management fee
Fund Issuer
WisdomTree
BATS
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 50 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Moderna, Inc. | Stock | 3.60% |
| 2 |  | Structure Therapeutics Inc. | Stock | 3.31% |
| 3 |  | Eli Lilly and Company | Stock | 3.17% |
| 4 |  | Natera, Inc | Stock | 3.10% |
| 5 |  | Johnson & Johnson | Stock | 3.02% |
| 6 |  | Pfizer Inc | Stock | 2.58% |
| 7 |  | BioNTech SE | Stock | 2.50% |
| 8 |  | Stoke Therapeutics, Inc | Stock | 2.46% |
| 9 |  | Amgen Inc. | Stock | 2.42% |
| 10 |  | United Therapeutics Corporation | Stock | 2.35% |
| 11 |  | Ionis Pharmaceuticals, Inc | Stock | 2.33% |
| 12 |  | Twist Bioscience Corporation | Stock | 2.27% |
| 13 |  | AstraZeneca PLC | Stock | 2.20% |
| 14 |  | REGENXBIO Inc | Stock | 2.16% |
| 15 |  | CRISPR Therapeutics AG | Stock | 2.16% |
| 16 |  | Amicus Therapeutics, Inc. | Stock | 2.15% |
| 17 | L LON:AZN | AstraZeneca PLC | Stock | 2.14% |
| 18 | L LSE:0QIU | Novo Nordisk A/S Class B | Stock | 2.12% |
| 19 |  | Gilead Sciences, Inc. | Stock | 2.07% |
| 20 |  | Immunome, Inc. | Stock | 2.03% |
| 21 | C CO:NSIS.B | Novozymes A/S Class B | Stock | 2.01% |
| 22 |  | Beam Therapeutics Inc | Stock | 1.98% |
| 23 | C CPH:NSIS.B | Novozymes A/S | Stock | 1.89% |
| 24 | C CPH:NOVO.B | Novo Nordisk A/S | Stock | 1.84% |
| 25 | S SWX:NOVN | Novartis AG | Stock | 1.65% |
| 26 |  | 10x Genomics, Inc | Stock | 1.62% |
| 27 |  | Krystal Biotech, Inc. | Stock | 1.62% |
| 28 |  | Exact Sciences Corporation | Stock | 1.61% |
| 29 |  | Agios Pharmaceuticals, Inc | Stock | 1.39% |
| 30 |  | Tempus AI, Inc. Class A Common Stock | Stock | 1.38% |
| 31 |  | Veracyte, Inc | Stock | 1.37% |
| 32 |  | Genmab A/S | Stock | 1.36% |
| 33 |  | Vertex Pharmaceuticals Incorporated | Stock | 1.36% |
| 34 |  | uniQure N.V | Stock | 1.31% |
| 35 |  | Roivant Sciences Ltd | Stock | 1.24% |
| 36 |  | Arrowhead Pharmaceuticals, Inc | Stock | 1.23% |
| 37 |  | argenx NV ADR | Stock | 1.22% |
| 38 |  | Corteva, Inc | Stock | 1.21% |
| 39 |  | Regeneron Pharmaceuticals, Inc | Stock | 1.20% |
| 40 |  | Bunge Limited | Stock | 1.19% |
| 41 |  | Repligen Corporation | Stock | 1.12% |
| 42 |  | Danaher Corporation | Stock | 1.10% |
| 43 |  | Intellia Therapeutics, Inc | Stock | 1.07% |
| 44 |  | Viking Therapeutics Inc | Stock | 1.06% |
| 45 |  | BioMarin Pharmaceutical Inc | Stock | 1.05% |
| 46 |  | Darling Ingredients Inc | Stock | 1.04% |
| 47 | C CO:ZEAL | Zealand Pharma A/S | Stock | 1.03% |
| 48 |  | Bristol-Myers Squibb Company | Stock | 1.00% |
| 49 | T TSE:4502 | Takeda Pharmaceutical Co. Ltd. | Stock | 0.99% |
| 50 |  | Sana Biotechnology, Inc | Stock | 0.98% |